{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:21:38Z","timestamp":1759710098203,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA241627","HL135895"],"award-info":[{"award-number":["CA241627","HL135895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neuroscience.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T20:31:43Z","timestamp":1676579503000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice"],"prefix":"10.1016","volume":"516","author":[{"given":"Giuseppe","family":"Cataldo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Lunzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyup","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-1485","authenticated-orcid":false,"given":"Henry L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Portoghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald A.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2023.02.006_b0005","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1073\/pnas.1305461110","article-title":"Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception","volume":"110","author":"Akg\u00fcn","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0010","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1021\/acschemneuro.8b00323","article-title":"Combined glia inhibition and opioid receptor agonism afford highly potent analgesics without tolerance","volume":"10","author":"Akg\u00fcn","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10072-011-0599-z","article-title":"Role of TNF-alpha during central sensitization in preclinical studies","volume":"32","author":"Andrade","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0026-895X(25)08898-4","article-title":"Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn","volume":"43","author":"Bleakman","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0025","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00001756-199804200-00044","article-title":"mGluR activation reveals a tonic NMDA component in inflammatory hyperalgesia","volume":"9","author":"Boxall","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2008.07.022","article-title":"Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy","volume":"1230","author":"Cata","year":"2008","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.neuroscience.2023.02.006_b0035","first-page":"1382","article-title":"The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward","volume":"159","author":"Cataldo","year":"2019","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-8-71","article-title":"The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy","volume":"8","author":"Deng","year":"2012","journal-title":"Mol Pain"},{"issue":"10","key":"10.1016\/j.neuroscience.2023.02.006_b0045","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/mt.2011.42","article-title":"Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain","volume":"19","author":"D'Mello","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pain.2003.09.017","article-title":"Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia","volume":"106","author":"Dolan","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0055","article-title":"A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance","volume":"27;20(1):154","author":"Dutta","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0060","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-3565(24)37138-1","article-title":"Ro 25\u20136981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro","volume":"283","author":"Fischer","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.626687","article-title":"Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy","volume":"11","author":"Fumagalli","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.neuroscience.2023.02.006_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0960-894X(01)00767-3","article-title":"[3H]-M-MPEP, a potent subtype-selective radioligand for the metabotropic glutamate receptor subtype 5","volume":"12","author":"Gasparini","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0075","article-title":"N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25\u20136981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression","volume":"18;8(1):7848","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0080","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1523\/JNEUROSCI.22-07-02660.2002","article-title":"Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia","volume":"22","author":"Hudson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jpain.2008.12.003","article-title":"Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat","volume":"10","author":"Joseph","year":"2009","journal-title":"J Pain"},{"issue":"20","key":"10.1016\/j.neuroscience.2023.02.006_b0095","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.0403-12.2012","article-title":"Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy","volume":"32","author":"Khasabova","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2014.09.008","article-title":"JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy","volume":"90","author":"Khasabova","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/j.pain.0000000000001448","article-title":"Pioglitazone, a PPAR\u03b3 agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress","volume":"160","author":"Khasabova","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0110","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1523\/JNEUROSCI.1069-18.2018","article-title":"Spinal RNF20-mediated histone H2B monoubiquitylation regulates mGluR5 transcription for neuropathic allodynia","volume":"38","author":"Lai","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J Pain"},{"unstructured":"Lewenstein MJ, Weiss U (1957) 14-hydroxydihydromorphinone. US2806033.","key":"10.1016\/j.neuroscience.2023.02.006_b0120"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0125","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1523\/JNEUROSCI.2587-15.2015","article-title":"VPS26A-SNX27 interaction-dependent MGLUR5 recycling in dorsal horn neurons mediates neuropathic pain in rats","volume":"35","author":"Lin","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0135","doi-asserted-by":"crossref","first-page":"251204","DOI":"10.1155\/2015\/251204","article-title":"Neurotrauma and inflammation: CNS and PNS responses","volume":"2015","author":"Mietto","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.neuroscience.2023.02.006_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0023677215575863","article-title":"Gender differences in a mouse model of chemotherapy-induced neuropathic pain","volume":"50","author":"Naji-Esfahani","year":"2016","journal-title":"Lab Anim"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0155","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M705661200","article-title":"Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors","volume":"283","author":"Perroy","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0160","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1097\/j.pain.0000000000001050","article-title":"Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 reduces neuropathic pain in mice","volume":"158","author":"Peterson","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0165","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/01.ANE.0000081061.12235.55","article-title":"The role of N-methyl-D aspartate (NMDA) receptors in pain: a review","volume":"97","author":"Petrenko","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.21506","article-title":"Effects of inflammation on the ultrastructural localization of spinal cord dorsal horn group I metabotropic glutamate receptors","volume":"505","author":"Pitcher","year":"2007","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2023.02.006_b0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1021\/jm00177a002","article-title":"A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities","volume":"23","author":"Portoghese","year":"1980","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2008.10.018","article-title":"Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain","volume":"215","author":"Qu","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107690","article-title":"Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting the NMDA receptor","volume":"160","author":"Shueb","year":"2019","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2014.09.008","article-title":"Targeting putitive mu opioid\/ metabotropic glutamate receptor-5 produces potent antinociception in chronic murine bone cancer model","volume":"743","author":"Smeester","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.neuroscience.2023.02.006_b0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.30802\/AALAS-CM-19-000066","article-title":"A Review of Strain and Sex Differences in Response to Pain and Analgesia in Mice","volume":"69","author":"Smith","year":"2019","journal-title":"Comp Med"},{"issue":"9","key":"10.1016\/j.neuroscience.2023.02.006_b0200","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/j.pain.0000000000001902","article-title":"The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids","volume":"161","author":"Speltz","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF01757696","article-title":"Pain due to nerve damage: are inflammatory mediators involved?","volume":"144","author":"Tracey","year":"1995","journal-title":"Inflamm Res"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0215","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1152\/jn.00692.2014","article-title":"Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy","volume":"113","author":"Uhelski","year":"2015","journal-title":"J Neurophysiol"},{"issue":"10","key":"10.1016\/j.neuroscience.2023.02.006_b0225","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/ejp.679","article-title":"Differences in cisplatin-induced mechanical allodynia in male and female mice","volume":"19","author":"Woller","year":"2015","journal-title":"Eur J Pain"},{"issue":"4","key":"10.1016\/j.neuroscience.2023.02.006_b0230","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nurt.2009.07.008","article-title":"Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain","volume":"6","author":"Wu","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2023.02.006_b0235","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pain.2007.06.001","article-title":"Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine","volume":"135","author":"Xiao","year":"2008","journal-title":"Pain"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452223000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452223000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:17:20Z","timestamp":1759681040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452223000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":43,"alternative-id":["S0306452223000775"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2023.02.006","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}